← Sanofi
Episodes featuring Sanofi
20 episodes, newest first.
- Nov 20, 2026
Biotech weighs AI disruption against a stronger 2027 deal cycleBiotech HangoutNov 20, 2026 - Nov 19, 2026
Anthropic’s debut tests AI valuations as markets retreatCNBC's "Fast Money"Nov 19, 2026 - Nov 17, 2026
AI agents automate attacks as Linux flaw and weak passwords persistCybersecurity HeadlinesNov 17, 2026 - Nov 12, 2026
Biotech’s uncertainty creates disciplined investment opportunitiesThe Acquirers PodcastNov 12, 2026 - Nov 10, 2026
Midterms Put FDA Leadership and Drug Pricing in PlayBioCentury This WeekNov 10, 2026 - Oct 30, 2026
Biotech weighs AI promise against biology’s stubborn bottlenecksBiotech HangoutOct 30, 2026 - Oct 30, 2026
Intel and Reddit stumble as Regeneron beats expectationsStock MoversOct 30, 2026 - Oct 30, 2026
European stocks rally as cities and SpaceX test new modelsStock MoversOct 30, 2026 - Oct 23, 2026
AI challenges biotech’s old company modelBiotech HangoutOct 23, 2026 - Oct 20, 2026
China reshapes biotech deals as RNAi reaches the brainBioCentury This WeekOct 20, 2026 - Oct 1, 2026
European stocks diverge as property, pharma and cities compete for growthStock MoversOct 1, 2026 - Sep 25, 2026
AI buildout collides with gambling, rates and real-world riskTBPNSep 25, 2026 - Aug 20, 2026
Brain inflammation may be a metabolic problem in disguiseExtend Podcast with Darshan Shah, MDAug 20, 2026 - Aug 6, 2026
Moderna rises on vaccine approval while Honeywell plunges on supply issuesStock MoversAug 6, 2026 - Jul 24, 2026
Cloud growth boosts SAP while Sanofi dips on halted drug trialStock MoversJul 24, 2026 - Jun 22, 2026
AbbVie targets Apogee in eleven billion dollar deal as Regenxbio advancesStock MoversJun 22, 2026 - Jun 12, 2026
Four top investors pitch their best live trades to All-In hostsAll-In with Chamath, Jason, Sacks & FriedbergJun 12, 2026 - Jun 10, 2026
European markets face retail and pharma setbacks while tech surgesStock MoversJun 10, 2026 - Jan 10, 2026
Cramer weighs rally momentum against health care dealmakingMad Money w/ Jim CramerJan 10, 2026 - Oct 22, 2025
Cramer warns speculation is outrunning market fundamentalsMad Money w/ Jim CramerOct 22, 2025